Personalizing lung cancer screening recommendations for heterogeneous populations: a microsimulation study
We estimate that half of the USPSTF lung cancer screening-eligible population is in a high-net-benefit group where lung cancer screening could be routinely encouraged. Current lung cancer screening eligibility criteria likely exclude many ever-smokers who are high net benefit and many more with intermediate net benefit.
Authors
- Jeremy B. Sussman (ORCID: https://orcid.org/0000-0002-2158-3618)
- Pianpian Cao (ORCID: https://orcid.org/0000-0001-8886-9672)
- Hormuzd A. Katki (ORCID: https://orcid.org/0000-0003-2002-0095)
- Tanner J Caverly (ORCID: https://orcid.org/0000-0002-6560-0547)
- Rafael Meza (ORCID: https://orcid.org/0000-0002-1076-5037)
- Joshua B. Rager (ORCID: https://orcid.org/0000-0001-9557-5672)
- Rodney A. Hayward
Institutions
- National Institutes of Health (US)
- Regenstrief Institute (US)
- Purdue University West Lafayette (US)
- University of Michigan (US)
- VA Ann Arbor Healthcare System (US)
- Michigan Medicine (US)
- VA Center for Clinical Management Research (US)
- BC Cancer Foundation (CA)
- National Cancer Institute (US)
- Department of Health and Human Services (US)
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis (US)
Publication Details
- Journal
- JNCI Journal of the National Cancer Institute
- Published
- 2025-10-29
- DOI
- https://doi.org/10.1093/jnci/djaf316
- Primary Topic
- Global Cancer Incidence and Screening
- Type
- article
- Field-Weighted Citation Impact
- 0.00